Stage IIIB Prostate Cancer AJCC v8 Not Yet Recruiting Phase 2 Trials for Apalutamide (DB11901)

IndicationStatusPhase
DBCOND0109671 (Stage IIIB Prostate Cancer AJCC v8)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06067269Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE TrialTreatment